[go: up one dir, main page]
Skip to main content

Advertisement

SpringerLink
Log in

Challenges in management of irritable bowel syndrome in children

  • Review Article
  • Published:
Indian Pediatrics Aims and scope Submit manuscript

Abstract

Irritable bowel syndrome (IBS) is a common cause of recurrent abdominal pain (RAP) in children and can be a debilitating experience for both child and family. Organic causes of RAP symptoms such as celiac and inflammatory bowel diseases should be excluded before a diagnosis of IBS is made. Treatment consists of dietary manipulation, drugs, and stress management.

Newer therapies may offer better control of symptoms with minimal side-effects. This article discusses the challenges faced by pediatricians in managing IBS and reviews management in the context of children from the Indian subcontinent.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bremner AR, Sandhu BK. Recurrent abdominal pain in childhood: The functional element. Indian Pediatr. 2009;46:375–379.

    CAS  PubMed  Google Scholar 

  2. El-Matary W, Spray C, Sandhu B. Irritable bowel syndrome: the commonest cause of recurrent abdominal pain in children. Eur J Pediatr. 2004;163:584–588.

    Article  PubMed  Google Scholar 

  3. Muller-Lissner S, Kock G, Talley NJ, Drossman D, Rueegg P, Dunger-Baldauf C, et al. Subject’s global assessment of relief: an appropriate method to assess the impact of treatment on irritable bowel syndrome-related symptoms in clinical trials. J Clin Epidemiol. 2003:56:310–316.

    Article  PubMed  Google Scholar 

  4. Rasquin A, Di Lorenzo C, Forbes D, Guiraldes E, Hyams J, Staiano A, et al. Childhood functional gastrointestinal disorders. Gastroenterology 2006;130: 1527–1537.

    Article  PubMed  Google Scholar 

  5. Guandalini S, Magazzu’ G, Chiaro A, La Balestra V, Di Nardo G, Gopalan S, et al. VSL#3 Improves symptoms in children with irritable bowel syndrome: A multicenter, eandomized, placebo-controlled, double-blind, crossover study. J Pediatr Gastroenterol Nutr. 2010;51: 24–30.

    Article  PubMed  Google Scholar 

  6. Spiller R, Garsed K. Infection, inflammation, and the irritable bowel syndrome. Dig Liver Dis. 2009;41:844–849.

    Article  CAS  PubMed  Google Scholar 

  7. Schwille-Kiuntke J, Enck P, Zendler C, Krieg M, Polster AV, Klosterhalfen S, et al. Postinfectious irritable bowel syndrome: follow-up of a patient cohort of confirmed cases of bacterial infection with Salmonella or Campylobacter. Neurogastroenterol Motil. 2011;23:e479–488.

    Article  CAS  PubMed  Google Scholar 

  8. Thabane M, Simunovic M, Akhtar-Danesh N, Garg AX, Clark WF, Collins SM, et al. An outbreak of acute bacterial gastroenteritis is associated with an increased incidence of irritable bowel syndrome in children. Am J Gastroenterol. 2010;105:933–939.

    Article  PubMed  Google Scholar 

  9. Dizdar V, Gilja OH, Hausken T. Increased visceral sensitivity in Giardia-induced postinfectious irritable bowel syndrome and functional dyspepsia. Effect of the 5HT3-antagonist ondansetron. Neurogastroenterol Motil. 2007;19:977–982.

    CAS  Google Scholar 

  10. Guzyeyeva GV. Giardia lamblia infection in hospitalized children with irritable bowel syndrome and dyspepsia: a prospective study. Faseb J. 2009;980.5 (Abstract).

  11. Ghoshal UC, Abraham P, Bhatt C, Choudhuri G, Bhatia SJ, Shenoy KT, et al. Epidemiological and clinical profile of irritable bowel syndrome in India: report of the Indian Society of Gastroenterology Task Force. Indian J Gastroenterol. 2008;27:22–28.

    PubMed  Google Scholar 

  12. Talley NJ. Genetics and Functional bowel disease. J Pediatr Gastroenterol Nutr. 2008; 47:680–682.

    Article  PubMed  Google Scholar 

  13. Mulak A, Paradowski L. Migraine and irritable bowel syndrome. Neurol Neurochir Pol. 2005;39:S55–S60.

    PubMed  Google Scholar 

  14. Hyams JS, Burke G, Davis PM, Rzepski B, Andrulonis PA. Abdominal pain and irritable bowel syndrome in adolescents: a community-based study. J Pediatr. 1996;129:220–226.

    Article  CAS  PubMed  Google Scholar 

  15. Bahar RJ, Collins BS, Steinmetz B, Ament ME. Doubleblind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents. J Pediatr. 2008;152:685–689.

    Article  CAS  PubMed  Google Scholar 

  16. Hoseini-Asl MK, Amra B. Prevalence of irritable bowel syndrome in Shahrekord, Iran. Indian J Gastroenterol. 2003;22:215–216.

    CAS  PubMed  Google Scholar 

  17. Candy DCA, Edwards E. The management of chronic constipation. Curr Pediatr. 2003;13: 101–106.

    Article  Google Scholar 

  18. Chiou E, Nurko S. Management of functional abdominal pain and irritable bowel syndrome in children and adolescents. Expert Rev Gastroenterol Hepatol. 2010;4:293–304.

    Article  PubMed Central  PubMed  Google Scholar 

  19. Benniga MA, Mayer EA. The Power of Placebo in Pediatric Functional Gastrointestinal Disease. Gastroenterology. 2009;137:1207–1210.

    Article  Google Scholar 

  20. Saps M, Youssef N, Miranda A, Nurko S, Hyman P, Cocjin J, et al. Multicenter, randomized placebocontrolled trial of amitriptyline in children with functional gastrointestinal disorders. Gastroenterology. 2009;137:1261–1269.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  21. Krogsbøll LT, Hróbjartsson A, Gøtzsche PC. Spontaneous improvement in randomised clinical trials: meta-analysis of three armed trials comparing no treatment, placebo and active intervention. BMC Med Res Methodol. 2009;9:1.

    Article  PubMed Central  PubMed  Google Scholar 

  22. Huertas-Ceballos AA, Logan S, Bennett C, Macarthur C. Psychosocial interventions for recurrent abdominal pain(RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD003014.

    Google Scholar 

  23. Rutten JM, Reitsma JB, Vlieger AM, Vlieger AM, Benniga MA. Gut-directed hypnotherapy for functional abdominal pain or irritable bowel syndrome in children: a systematic review. Arch Dis Child. 2013; 98:252–257.

    Article  PubMed  Google Scholar 

  24. Huertas-Ceballos AA, Logan S, Bennett C, Macarthur C. Pharmacological interventions for recurrent abdominal pain(RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD003017.

    Google Scholar 

  25. Lebel AA. Pharmacology. J Pediatr Gastroenterol Nutr. 2008;47:703–705.

    Article  PubMed  Google Scholar 

  26. Chey WY, Jin HO, Lee MH, Sun SW, Lee KY. Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea. Am J Gastroenterol. 2001;96:1499–1506.

    Article  CAS  PubMed  Google Scholar 

  27. Awad R, Dibildox M, Ortiz F. Irritable bowel syndrome treatment using pinaverium bromide as a calcium channel blocker. A randomized double-blind placebo-controlled trial. Acta Gastroenterol Latinoam. 1995;25:137–144.

    CAS  PubMed  Google Scholar 

  28. Karabulut GS, Beer OF, Erginöz E, Kutlu T, Cokuðraη FÇ, Erkan T. The incidence of irritable bowel syndrome in children using the Rome III Criteria and the effect of trimebutine treatment. J Neurogastroenterol Motil. 2013;19:90–93.

    Article  PubMed Central  PubMed  Google Scholar 

  29. Teitelbaum JE, Arora R. Long-term efficacy of low-dose tricyclic antidepressants for children with functional gastrointestinal disorders. J Pediatr Gastroenterol Nutr. 2011;53:260–264.

    Article  PubMed  Google Scholar 

  30. Snook J, Shepherd HA. Bran supplementation in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 1994;8:511–514.

    Article  CAS  PubMed  Google Scholar 

  31. Paul SP, Barnard P, Edate S, Candy DC. Stool consistency and abdominal pain in irritable bowel syndrome may be improved by partially hydrolysed guar gum. J Pediatr Gastroenterol Nutr. 2011;53:582–583.

    PubMed  Google Scholar 

  32. NICE CG99. Diagnosis and management of idiopathic childhood constipation in primary and secondary care. http://www.nice.org.uk/nicemedia/live/12993/48721/48721.pdf.

  33. Cann PA, Read NW, Holdsworth CD, Barends D. Role of loperamide and placebo in management of irritable bowel syndrome (IBS). Dig Dis Sci. 1984;29:239–247.

    Article  CAS  PubMed  Google Scholar 

  34. Pimentel M, Lembo A, Chey WD, Zakko S, Ringel Y, Yu J, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med. 2011;364:22–32.

    Article  CAS  PubMed  Google Scholar 

  35. Giorgio V, D’ Andrea V, Coccia P, Filoni S, Rendeli C, Fundarò C. Efficacy of rifaximin for SIBO treatment in IBS children. Pediatr. Res. 2010;68,144.

    Article  Google Scholar 

  36. Huertas-Ceballos AA, Logan S, Bennett C, Macarthur C. Dietary interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD003019.

    Google Scholar 

  37. Romano C, Ferrau V, Cavataio F, Iacono G, Spina M, Lionetti E, et al. Lactobacillus reuteri in children with functional abdominal pain (FAP). J Paediatr Child Health. 2010.Jul8. (Epub ahead of print).

    Google Scholar 

  38. Chen CC, Walker WA. Clinical applications of probiotics in gastrointestinal disorders in children. Natl Med J India. 2011;24:153–160.

    PubMed  Google Scholar 

  39. Romano C, Comito D, Famini A, Calamarà S, Loddo I. Partially hydrolyzed guar gum in pediatric functional abdominal pain. World J Gastroenterol. 2013;19:235–240.

    Article  PubMed  Google Scholar 

  40. Brands MM, Purperhart H, Deckers-Kocken JM. A pilot study of yoga treatment in children with functional abdominal pain and irritable bowel syndrome. Complement Ther Med. 2011;19:109–114.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bristol Royal Hospital for Children, Bristol, BS2 8BJ, UK

    Siba Prosad Paul

  2. Western Sussex Hospitals NHS Foundation Trust, Chichester, PO19 6SE, UK

    Penny Barnard & David C. A. Candy

  3. Evelina Children’s Hospital, London, SE1 7EH., UK

    Charlotte Bigwood

  4. Department of Pediatric Gastroenterology, Bristol Royal Hospital for Children, Paul O’Gorman Building, Upper Maudlin Street, Bristol, BS2 8BJ, UK

    Siba Prosad Paul

Authors
  1. Siba Prosad Paul
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Penny Barnard
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Charlotte Bigwood
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. David C. A. Candy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Siba Prosad Paul.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Paul, S.P., Barnard, P., Bigwood, C. et al. Challenges in management of irritable bowel syndrome in children. Indian Pediatr 50, 1137–1143 (2013). https://doi.org/10.1007/s13312-013-0308-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13312-013-0308-5

Keywords

Search

Navigation